Takeda Pharmaceutical Company
TAK17.7501.31% ( +0.230 )
Takeda Pharmaceutical Company (TAK)
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers phar...
- Open
- 17.650
- High
- 17.830
- Low
- 17.570
- Prev. Close
- 17.520
- Volume
- 5.24M
- Turnover
- 92.95M
- Avg Price
- 17.743
- Bid/Ask Ratio
- --
- Amplitude
- 1.48%
- 52wk High
- 18.895
- Volume Ratio
- 1.29
- Turnover Ratio
- 0.17%
Takeda Pharmaceutical Company Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$21.0118.37%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 4 hours ago
Takeda Pharmaceutical Company: Revenue up 10.2% on FX tailwinds; core profit flat at CER; FY2026 outlook cautious
- Quartr · 5 hours ago
Takeda Pharmaceutical Company: Q1 FY2026 delivered robust core revenue growth, driven by new launches and disciplined investment
- PUBT · 5 hours ago
Takeda forecasts FY2026 core revenue of ¥ 4,640 billion
- PUBT · 5 hours ago
Takeda FY26 Q1 operating profit rises 9.1% to JPY 201.4 billion
- StockTitan · 13 hours ago
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track | TAK Stock News
- Global Report · 1 day ago, 04:19 AM
Inside the M&A Shuffles: Takeda, ZTO, and Pentair's $1.4B Buyout Signal
